Table 2.
Differentiation of SJIA versus bacterial infections and NOMID with S100A12 at various cut-offs.
Parameter | Area under the curve | Cut-off | Sensitivity | Specificity | Positive Likelihood ratio |
---|---|---|---|---|---|
SJIA vs infections | 0.881 ± 0.078 | 800 ng/ml | 85% | 89% | 7.7 |
1400 ng/ml | 66% | 94% | 11.0 | ||
2750 ng/ml | 55% | 97% | 18.3 | ||
SJIA vs NOMID | 0.866 ± 0.084 | 800 ng/ml | 84% | 72% | 3.0 |
1400 ng/ml | 66% | 89% | 6.0 | ||
2750 ng/ml | 54% | 94% | 9.0 | ||
SJIA vs MWS | 0.972 ± 0.031 | 1000 ng/ml | 78% | 100% | n.a. |
SJIA vs ALL | 0.981 ± 0.024 | 1000 ng/ml | 78% | 100% | n.a. |
SJIA vs AML | 1.000 ± 0.0 | 150 ng/ml | 97% | 100% | n.a. |
SJIA vs healthy controls | 0.994 ± 0.012 | 150 ng/ml | 98% | 100% | n.a. |
vs=versus; n.a.=not applicable, LR+ is going to infinity in these cases